Feb 17, 2026 08:02AM

Feb 17, 2026 08:00AM

Nov 18, 2025 04:27PM

Nov 13, 2025 08:00AM

Nov 10, 2025 08:01AM

Nov 10, 2025 08:00AM

Oct 28, 2025 08:01AM Cingulate reports positive phase 3 trial results for ADHD drug CTx-1301

Oct 28, 2025 08:00AM

Oct 14, 2025 08:04AM

Oct 14, 2025 08:00AM

Aug 21, 2025 04:35PM

Aug 19, 2025 08:45AM

Jul 29, 2025 08:01AM

Jul 29, 2025 08:00AM Cingulate Receives $4.3M Waiver from FDA Ahead of Imminent Filing for Marketing Approval of Lead ADHD Asset CTx-1301

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All